Instituto Português Oncologia Francisco Gentil do Porto - Oncologia Medica

Porto 4200-072

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma — Running, not enrolling